CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lukaka@cato-chem.com
首页Home / 产品查询Product Search / 按品种找对照品By drug substance / 富马酸丙酚替诺福韦Tenofovir Alafenamide Fumarate
Tenofovir Alafenamide Fumarate

富马酸丙酚替诺福韦 杂质对照品Tenofovir Alafenamide Fumarate Impurities

41 个杂质条目41 impurity entries

本页汇总 富马酸丙酚替诺福韦 的 41 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 41 impurity reference standards of Tenofovir Alafenamide Fumarate. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 富马酸丙酚替诺福韦(Tenofovir Alafenamide Fumarate)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesAnalytical Lifecycle Management (ALM) and Analytical Quality by Design (AQbD) for analytical procedure development of related substances in tenofovir alafenamide fumarate tablets
    Journal of pharmaceutical and biomedical analysis · 2022 · Teng J et al.  ·  PMID 34678556  ·  DOI
  2. 杂质研究Impurity studiesSimultaneous determination of emtricitabine, tenofovir alafenamide fumarate and dolutegravir sodium by validated stability-indicating RP-HPLC-DAD method
    Annales pharmaceutiques francaises · 2023 · Rathod SM et al.  ·  PMID 36037931  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate
    Turkish journal of pharmaceutical sciences · 2021 · Attaluri T et al.  ·  PMID 34496481  ·  DOI
  4. 分析方法Analytical MethodsUsing artificial neural network and multivariate calibration methods for simultaneous spectrophotometric analysis of Emtricitabine and Tenofovir alafenamide fumarate in pharmaceutical formulation of HIV drug
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2019 · Arabzadeh V et al.  ·  PMID 30831397  ·  DOI
  5. 分析方法Analytical MethodsValidation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs
    Journal of pharmaceutical and biomedical analysis · 2018 · Hummert P et al.  ·  PMID 29433097  ·  DOI

富马酸丙酚替诺福韦 —— 原料药与杂质对照品Tenofovir Alafenamide Fumarate — drug substance & impurities

共 41 个条目(含原料药本体)41 items incl. the drug substance
Tenofovir Alafenamide Fumarate structure
原料药 APIAPI
富马酸丙酚替诺福韦Tenofovir Alafenamide Fumarate
Tenofovir Alafenamide Fumarate
CAS No.379270-38-9
Chemical FormulaC21H29N6O5P·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Hemifumarate structure
—
半富马酸丙酚替诺福韦Tenofovir Alafenamide Hemifumarate
Tenofovir Alafenamide Hemifumarate
CAS No.1392275-56-7
Chemical Formula2(C21H29N6O5P)·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide structure
—
丙酚替诺福韦Tenofovir Alafenamide
Tenofovir Alafenamide
CAS No.379270-37-8
Chemical FormulaC21H29N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 1 Lithium Salt structure
1
富马酸丙酚替诺福韦杂质1 锂盐Tenofovir Alafenamide Fumarate Impurity 1 Lithium Salt
Tenofovir Alafenamide Fumarate Impurity 1 Lithium Salt
CAS No.2734880-21-6
Chemical FormulaC15H24LiN6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 1 structure
1
富马酸丙酚替诺福韦杂质1Tenofovir Alafenamide Fumarate Impurity 1
Tenofovir Alafenamide Fumarate Impurity 1
CAS No.851456-00-3
Chemical FormulaC15H25N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 3 structure
3
富马酸丙酚替诺福韦杂质3Tenofovir Alafenamide Fumarate Impurity 3
Tenofovir Alafenamide Fumarate Impurity 3
CAS No.342631-41-8
Chemical FormulaC21H22N5O4P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 6 structure
6
富马酸丙酚替诺福韦杂质6Tenofovir Alafenamide Fumarate Impurity 6
Tenofovir Alafenamide Fumarate Impurity 6
CAS No.1244022-52-3
Chemical FormulaC8H11N5O
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 8 structure
8
富马酸丙酚替诺福韦杂质8Tenofovir Alafenamide Fumarate Impurity 8
Tenofovir Alafenamide Fumarate Impurity 8
CAS No.2055343-42-3
Chemical FormulaC21H29N6O5P·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 12 structure
12
富马酸丙酚替诺福韦杂质12Tenofovir Alafenamide Fumarate Impurity 12
Tenofovir Alafenamide Fumarate Impurity 12
CAS No.1607007-18-0
Chemical FormulaC18H26N10O7P2
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 13 structure
13
富马酸丙酚替诺福韦杂质13Tenofovir Alafenamide Fumarate Impurity 13
Tenofovir Alafenamide Fumarate Impurity 13
CAS No.1422343-76-7
Chemical FormulaC21H29N6O5P·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 13 Monomer structure
13
富马酸丙酚替诺福韦杂质13 单体Tenofovir Alafenamide Fumarate Impurity 13 Monomer
Tenofovir Alafenamide Fumarate Impurity 13 Monomer
CAS No.383365-04-6
Chemical FormulaC21H29N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 16 Fumarate-d3 structure
16
富马酸丙酚替诺福韦杂质16 富马酸盐-d3Tenofovir Alafenamide Fumarate Impurity 16 Fumarate-d3
Tenofovir Alafenamide Fumarate Impurity 16 Fumarate-d3
CAS No.1948248-12-1
Chemical FormulaC21H26D3N6O5P·C4H4O4
Purity>95%询价On request
Tenofovir Alafenamide Fumarate Impurity 16 structure
16
富马酸丙酚替诺福韦杂质16Tenofovir Alafenamide Fumarate Impurity 16
Tenofovir Alafenamide Fumarate Impurity 16
CAS No.2053424-88-5
Chemical FormulaC21H29N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 16 Fumarate structure
16
富马酸丙酚替诺福韦杂质16 富马酸盐Tenofovir Alafenamide Fumarate Impurity 16 Fumarate
Tenofovir Alafenamide Fumarate Impurity 16 Fumarate
CAS No.2095734-38-4
Chemical FormulaC21H29N6O5P·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 20 structure
20
富马酸丙酚替诺福韦杂质20Tenofovir Alafenamide Fumarate Impurity 20
Tenofovir Alafenamide Fumarate Impurity 20
CAS No.2126010-05-5
Chemical FormulaC18H24N5O4P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 21 structure
21
富马酸丙酚替诺福韦杂质21Tenofovir Alafenamide Fumarate Impurity 21
Tenofovir Alafenamide Fumarate Impurity 21
CAS No.376633-26-0
Chemical FormulaC15H25N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 22 structure
22
富马酸丙酚替诺福韦杂质22Tenofovir Alafenamide Fumarate Impurity 22
Tenofovir Alafenamide Fumarate Impurity 22
CAS No.1234081-04-9
Chemical FormulaC18H23N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 25 structure
25
富马酸丙酚替诺福韦杂质25Tenofovir Alafenamide Fumarate Impurity 25
Tenofovir Alafenamide Fumarate Impurity 25
CAS No.2488598-61-2
Chemical FormulaC15H18N5O4P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 28 structure
28
富马酸丙酚替诺福韦杂质28Tenofovir Alafenamide Fumarate Impurity 28
Tenofovir Alafenamide Fumarate Impurity 28
CAS No.379270-35-6
Chemical FormulaC15H18N5O4P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 29 Monomer structure
29
富马酸丙酚替诺福韦杂质29 单体Tenofovir Alafenamide Fumarate Impurity 29 Monomer
Tenofovir Alafenamide Fumarate Impurity 29 Monomer
CAS No.379270-36-7
Chemical FormulaC21H29N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 30 Monomer structure
30
富马酸丙酚替诺福韦杂质30 单体Tenofovir Alafenamide Fumarate Impurity 30 Monomer
Tenofovir Alafenamide Fumarate Impurity 30 Monomer
CAS No.2053423-98-4
Chemical FormulaC21H29N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 30 structure
30
富马酸丙酚替诺福韦杂质30Tenofovir Alafenamide Fumarate Impurity 30
Tenofovir Alafenamide Fumarate Impurity 30
CAS No.2053427-57-7
Chemical FormulaC21H29N6O5P·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 33 structure
33
富马酸丙酚替诺福韦杂质33Tenofovir Alafenamide Fumarate Impurity 33
Tenofovir Alafenamide Fumarate Impurity 33
CAS No.1878175-77-9
Chemical FormulaC17H23N10O4P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 48 Hydrochloride structure
48
富马酸丙酚替诺福韦杂质48 盐酸盐Tenofovir Alafenamide Fumarate Impurity 48 Hydrochloride
Tenofovir Alafenamide Fumarate Impurity 48 Hydrochloride
CAS No.2577249-58-0
Chemical FormulaC9H18N2O3·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 48 structure
48
富马酸丙酚替诺福韦杂质48Tenofovir Alafenamide Fumarate Impurity 48
Tenofovir Alafenamide Fumarate Impurity 48
CAS No.431949-21-2
Chemical FormulaC9H18N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 68 structure
68
富马酸丙酚替诺福韦杂质68Tenofovir Alafenamide Fumarate Impurity 68
Tenofovir Alafenamide Fumarate Impurity 68
CAS No.4712-55-4
Chemical FormulaC12H11O3P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 89 structure
89
富马酸丙酚替诺福韦杂质89Tenofovir Alafenamide Fumarate Impurity 89
Tenofovir Alafenamide Fumarate Impurity 89
CAS No.115-86-6
Chemical FormulaC18H15O4P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 91 structure
91
富马酸丙酚替诺福韦杂质91Tenofovir Alafenamide Fumarate Impurity 91
Tenofovir Alafenamide Fumarate Impurity 91
CAS No.205876-07-9
Chemical FormulaC18H12Br3O3P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 93 structure
93
富马酸丙酚替诺福韦杂质93Tenofovir Alafenamide Fumarate Impurity 93
Tenofovir Alafenamide Fumarate Impurity 93
CAS No.37844-58-9
Chemical FormulaC18H12Br3O3P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 94 structure
94
富马酸丙酚替诺福韦杂质94Tenofovir Alafenamide Fumarate Impurity 94
Tenofovir Alafenamide Fumarate Impurity 94
CAS No.2067354-17-8
Chemical FormulaC27H33N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 94 Fumarate structure
94
富马酸丙酚替诺福韦杂质94 富马酸盐Tenofovir Alafenamide Fumarate Impurity 94 Fumarate
Tenofovir Alafenamide Fumarate Impurity 94 Fumarate
CAS No.2067354-49-6
Chemical FormulaC27H33N6O5P·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 95 structure
95
富马酸丙酚替诺福韦杂质95Tenofovir Alafenamide Fumarate Impurity 95
Tenofovir Alafenamide Fumarate Impurity 95
CAS No.2095734-30-6
Chemical FormulaC30H38N7O6P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 96 structure
96
富马酸丙酚替诺福韦杂质96Tenofovir Alafenamide Fumarate Impurity 96
Tenofovir Alafenamide Fumarate Impurity 96
CAS No.2093446-45-6
Chemical FormulaC23H30N7O6P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 96 Fumarate structure
96
富马酸丙酚替诺福韦杂质96 富马酸盐Tenofovir Alafenamide Fumarate Impurity 96 Fumarate
Tenofovir Alafenamide Fumarate Impurity 96 Fumarate
CAS No.2093446-53-6
Chemical FormulaC23H30N7O6P·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 98 Monomer structure
98
富马酸丙酚替诺福韦杂质98 单体Tenofovir Alafenamide Fumarate Impurity 98 Monomer
Tenofovir Alafenamide Fumarate Impurity 98 Monomer
CAS No.390409-48-0
Chemical FormulaC20H27N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 100 structure
100
富马酸丙酚替诺福韦杂质100Tenofovir Alafenamide Fumarate Impurity 100
Tenofovir Alafenamide Fumarate Impurity 100
CAS No.5382-00-3
Chemical FormulaC12H10ClO2P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 101 structure
101
富马酸丙酚替诺福韦杂质101Tenofovir Alafenamide Fumarate Impurity 101
Tenofovir Alafenamide Fumarate Impurity 101
CAS No.3426-89-9
Chemical FormulaC6H5Cl2OP
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 102 Monomer structure
102
富马酸丙酚替诺福韦杂质102 单体Tenofovir Alafenamide Fumarate Impurity 102 Monomer
Tenofovir Alafenamide Fumarate Impurity 102 Monomer
CAS No.390409-27-5
Chemical FormulaC19H25N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 106 structure
106
富马酸丙酚替诺福韦杂质106Tenofovir Alafenamide Fumarate Impurity 106
Tenofovir Alafenamide Fumarate Impurity 106
CAS No.1571076-15-7
Chemical FormulaC22H31N6O5P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 107 structure
107
富马酸丙酚替诺福韦杂质107Tenofovir Alafenamide Fumarate Impurity 107
Tenofovir Alafenamide Fumarate Impurity 107
CAS No.4218-62-6
Chemical FormulaC19H17O4P
Purity>95%询价On request
10mg25mg50mg100mg
Tenofovir Alafenamide Fumarate Impurity 108 structure
108
富马酸丙酚替诺福韦杂质108Tenofovir Alafenamide Fumarate Impurity 108
Tenofovir Alafenamide Fumarate Impurity 108
CAS No.841-46-3
Chemical FormulaC14H15O4P
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

富马酸丙酚替诺福韦 —— 研究文献与合成路线Tenofovir Alafenamide Fumarate — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 富马酸丙酚替诺福韦 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Tenofovir Alafenamide Fumarate. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its degradation and stability behaviour with tenofovir disoproxil fumarate
    Golla VM, Kurmi M, Shaik K, et al. · Journal of pharmaceutical and biomedical analysis · 2016 · 被引 40cited 40

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

富马酸丙酚替诺福韦 杂质谱研究要点Tenofovir Alafenamide Fumarate — impurity profiling notes

下面这些是拿到 富马酸丙酚替诺福韦 的 41 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 41 impurity entries for Tenofovir Alafenamide Fumarate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances